Ratings China Life Insurance Company Limited Shanghai S.E.

Equities

601628

CNE000001Q93

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
30.66 ^CNY	-0.49%		+7.73%	+8.15%

Apr. 26	Transcript : China Life Insurance Company Limited, Q1 2024 Earnings Call, Apr 26, 2024
Apr. 26	China Life Insurance Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Its low valuation, with P/E ratio at 7.08 and 5.91 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company's share price in relation to its net book value makes it look relatively cheap.
The company is one of the best yield companies with high dividend expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last few months, analysts have been revising downwards their earnings forecast.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
CHINA LIFE INSURANCE COMPANY LIMITED	+8.15%	98.09B	-
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.	+2.63%	95.12B	B
AIA GROUP LIMITED	-12.78%	82.72B	B+
LIFE INSURANCE CORPORATION OF INDIA	+20.02%	74.13B	D+
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.	+8.49%	30.52B	B
JAPAN POST HOLDINGS CO., LTD.	+20.29%	28.07B	B
FUBON FINANCIAL HOLDING CO., LTD.	+6.64%	27.62B	A
SBI LIFE INSURANCE COMPANY LIMITED	+1.98%	17.24B	C+
HDFC LIFE INSURANCE COMPANY LIMITED	-10.88%	15.04B	B
NN GROUP N.V.	+20.62%	12.68B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes